Kim Hofman

Senior Research Associate at Lava Therapeutics B.V.

Kim Hofman has four years of experience in the biotechnology industry. In 2020, they began working as a Research Associate at Lava Therapeutics B.V., a biotechnology company that creates and develops next generation γδ T cell engaging bispecific antibodies for the treatment of cancer. Prior to this, they completed research internships at Sanquin in 2018 and AIMM Therapeutics in 2018, as well as a research internship at Universiteit van Amsterdam in 2017.

Kim Hofman completed a Bachelor of Science in Biomedical Sciences from the University of Amsterdam between 2014 and 2017. Kim then went on to complete a Master of Science in Biomedical Sciences (Oncology track) from the University of Amsterdam between 2017 and 2019.

Location

Nieuwegein, Netherlands

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Lava Therapeutics B.V.

Lava Therapeutics is focused on applying its expertise in gamma-delta T-cell engagers (TCEs) to transform cancer therapy.


Industries

Employees

51-200

Links